Pending EO 12866 Regulatory Review

RIN: 1117-ZA13	Received Date: 10/14/2026
Title: Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for sale), Hydromorphone and Methylphenidate (for sale) Pursuant to 21 U.S.C. 826(h)
Agency/Subagency: DOJ / DEA	Stage: Notice
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No